REPROCELL USA Inaugurates GMP Manufacturing Facility for Stem Cells

REPROCELL USA Inaugurates GMP Manufacturing Facility for Stem Cells REPROCELL is pleased to announce the offering of Master Cell Bank (MCB) manufacturing service for generation of Human Induced Pluripotent Cells (hiPSC) and Human Mesenchymal Stem Cells (hMSC) for human therapeutic applications. BELTSVILLE, Md., May 29, 2024 /PRNewswire/ — REPROCELL has been producing clinically relevant human induced pluripotent…

Bioserve Biotechnologies and RISVI Trading Announce New Distributorship Agreement in Qatar

Bioserve Biotechnologies and RISVI Trading Announce New Distributorship Agreement in Qatar. Hyderabad, India and Doha, Qatar – May 6, 2024 – Bioserve Biotechnologies (India) Private Limited, a leader in molecular biology products, is excited to announce a new distributorship agreement with RISVI Trading W.L.L., a renowned trading company based in Doha, Qatar. This strategic partnership…

Bioserve Biotechnologies Partners with BioMavericks Ltd. to Expand Presence in the UK market.

Bioserve Biotechnologies Partners with BioMavericks Ltd. to Expand Presence in the UK market. Hyderabad, India, 27th September 2023: Bioserve Biotechnologies (India) Private Limited, a leader in molecular biology products, is teaming up with BioMavericks Ltd., a UK-based company. This partnership will allow Bioserve to extend its molecular biology product distribution, including DNA oligonucleotide synthesis across the…

REPROCELL invests in Histocell, S.L. a Spain-based CDMO

REPROCELL invests in Histocell, S.L. a Spain-based CDMO Yokohama Japan, 23 November 2022: REPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem cell (iPSC) service offerings. Histocell is a CDMO based in Bilbao, Spain, with an authorized Advanced Therapy Medical Product (ATMP) manufacturing facility that offers GMP-grade manufacturing services for…